Area of research
Oncology · Hematology
Research interest
Research interests include Multiple Myeloma Research and Treatments, Cancer Research and Treatments, Ubiquitin and proteasome pathways, and Peptidase Inhibition and Analysis.
Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasion
<scp>TRIM</scp>13 (<scp>RFP</scp>2) downregulation decreases tumour cell growth in multiple myeloma through inhibition of <scp>NF K</scp>appa <scp>B</scp> pathway and proteasome activity
Targeted Disruption of the BCL9/β-Catenin Complex Inhibits Oncogenic Wnt Signaling
Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myeloma